EUVIMEDEUVIMED entdecken
Open Access

Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation

Katia Bravo-Jaimes, Xiuju Wu, Leigh C Reardon, Gentian Lluri, Jeannette P Lin, Jeremy P Moore, Glen van Arsdell, Reshma Biniwale, Ming-Sing Si, Bita V Naini, Robert Venick, Sammy Saab und 7 weitere

Journal of the American College of Cardiology · 2024-02 · 83 (7) · 726-738

DOI: 10.1016/j.jacc.2023.12.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American College of Cardiology, 2024-02. Verfasst von Katia Bravo-Jaimes und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA; Ahmanson/UCLA Adult Congenital Heart Disease Center, University of Ca…. Hauptthemen laut MEDLINE: Fontan Procedure, Liver Diseases, Heart Defects, Congenital. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The molecular mechanisms underlying Fontan-associated liver disease (FALD) remain largely unknown. OBJECTIVES: This study aimed to assess intrahepatic transcriptomic differences among patients with FALD according to the degree of liver fibrosis and clinical outcomes. METHODS: This retrospective cohort study included adults with the Fontan circulation. Baseline clinical, laboratory, imaging, and hemodynamic data as well as a composite clinical outcome (CCO) were extracted from medical records. Patients were classified into early or advanced fibrosis. RNA was isolated from formalin-fixed paraffin-embedded liver biopsy samples; RNA libraries were constructed with the use of an rRNA depletion method and sequenced on an Illumina Novaseq 6000. Differential gene expression and gene ontology analyses were performed with the use of DESeq2 and Metascape. RESULTS: A total of 106 patients (48% male, median age 31 years [IQR: 11.3 years]) were included. Those with advanced fibrosis had higher B-type natriuretic peptide levels and Fontan, mean pulmonary artery, and capillary wedge pressures. The CCO was present in 23 patients (22%) and was not predicted by advanced liver fibrosis, right ventricular morphology, presence of aortopulmonary collaterals, or Fontan pressures on multivariable analysis. Samples with advanced fibrosis had 228 upregulated genes compared with early fibrosis. Samples with the CCO had 894 upregulated genes compared with those without the CCO. A total of 136 upregulated genes were identified in both comparisons and were enriched in cellular response to cytokine stimulus or oxidative stress, VEGFA-VEGFR2 signaling pathway, TGF-β signaling pathway, and vasculature development. CONCLUSIONS: Patients with FALD and advanced fibrosis or the CCO exhibited upregulated genes related to inflammation, congestion, and angiogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fontan ProcedureLiver DiseasesHeart Defects, CongenitalAdultHumansMaleFemaleRetrospective StudiesLiver CirrhosisFibrosisGene Expression ProfilingRNA

Stichwörter der Autor:innen

Fontan outcomesFontan-associated liver diseaseliver fibrosissingle ventricletranscriptomics

Substanzen

RNA

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA; Ahmanson/UCLA Adult Congenital Heart Disease Center, University of California, Los Angeles, California, USA.
  • Division of Cardiology, Department of Medicine, University of California, Los Angeles, California, USA.
  • Ahmanson/UCLA Adult Congenital Heart Disease Center, University of California, Los Angeles, California, USA; Department of Pediatric Cardiology, University of California, Los Angeles Mattel Children's Hospital, Los Ange…
  • Ahmanson/UCLA Adult Congenital Heart Disease Center, University of California, Los Angeles, California, USA; Division of Cardiology, Department of Medicine, University of California, Los Angeles, California, USA.
  • Ahmanson/UCLA Adult Congenital Heart Disease Center, University of California, Los Angeles, California, USA; Division of Congenital Cardiovascular Surgery, University of California, Los Angeles Mattel Children's Hospita…
  • Department of Pathology and Lab Services, University of California, Los Angeles, California, USA.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Bravo-Jaimes, K., Wu, X., Reardon, L. C., Lluri, G., Lin, J. P., Moore, J. P., van Arsdell, G., Biniwale, R., Si, M. S., Naini, B. V., Venick, R., Saab, S., Wray, C. L., Ponder, R., Rosenthal, C., Klomhaus, A., Böstrom, K. I., Aboulhosn, J. A., & Kaldas, F. M. (2024). Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation. Journal of the American College of Cardiology, 83(7), 726-738. https://doi.org/10.1016/j.jacc.2023.12.005

Vancouver

Bravo-Jaimes K, Wu X, Reardon LC, Lluri G, Lin JP, Moore JP, et al. Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation. Journal of the American College of Cardiology. 2024;83(7):726-738. doi:10.1016/j.jacc.2023.12.005

BibTeX
@article{BravoJaimes2024,
  author = {Bravo-Jaimes, Katia and Wu, Xiuju and Reardon, Leigh C and Lluri, Gentian and Lin, Jeannette P and Moore, Jeremy P and van Arsdell, Glen and Biniwale, Reshma and Si, Ming-Sing and Naini, Bita V and Venick, Robert and Saab, Sammy and Wray, Christopher L and Ponder, Reid and Rosenthal, Carl and Klomhaus, Alexandra and Böstrom, Kristina I and Aboulhosn, Jamil A and Kaldas, Fady M},
  title = {Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation},
  journal = {Journal of the American College of Cardiology},
  year = {2024},
  volume = {83},
  number = {7},
  pages = {726--738},
  doi = {10.1016/j.jacc.2023.12.005}
}
Kostenlos starten →